社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
晶泰控股(02228)
7.410
-0.310
-4.02%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
虾米焗芝士
·
15分钟前
$晶泰控股(02228)$
晶泰与代谢疾病领域龙头甘李药业联合共建了“AI智肽递送实验室”，重点围绕代谢性慢病领域开展研究，标志着双方在AI赋能多肽药物研发领域的合作步入全面深化阶段。
$晶泰控股(02228)$ 晶泰与代谢疾病领域龙头甘李药业联合共建了“AI智肽递送实验室”，重点围绕代谢性慢病领域开展研究，标志着双方在AI赋能多肽药物研...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
打铁不如李铁
·
11:35
$晶泰控股(02228)$
晶泰控股的核心价值在于其“AI+药物发现”和“智能自动化解决方案”业务。
$晶泰控股(02228)$ 晶泰控股的核心价值在于其“AI+药物发现”和“智能自动化解决方案”业务。
回复
评论
点赞
1
编组 21备份 2
分享
举报
行稳致远之
·
07-13 21:57
$晶泰控股(02228)$
晶泰合作开发的候选药物SIGX1094 1期临床安全性良好，预计2026年第三季度进入2期临床，已获FDA孤儿药资格及快速通道认定
$晶泰控股(02228)$ 晶泰合作开发的候选药物SIGX1094 1期临床安全性良好，预计2026年第三季度进入2期临床，已获FDA孤儿药资格及快速通道认定
回复
评论
点赞
1
编组 21备份 2
分享
举报
虾米焗芝士
·
07-10
$晶泰控股(02228)$
晶泰之所以值得，核心在于它规避了亲自下场去做药的风险，却又通过诸多捆绑可以分得最终的果实，把创新药的研发做成了进可攻、退可守的确定性生意。
$晶泰控股(02228)$ 晶泰之所以值得，核心在于它规避了亲自下场去做药的风险，却又通过诸多捆绑可以分得最终的果实，把创新药的研发做成了进可攻、退可守的...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
骏马飞驰吧
·
07-10
$晶泰控股(02228)$
港股创新药ETF（513780）近日明显上涨，晶泰为成分股核心引擎，板块共振效应显著
$晶泰控股(02228)$ 港股创新药ETF（513780）近日明显上涨，晶泰为成分股核心引擎，板块共振效应显著
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
标杆选手
·
07-09
$晶泰控股(02228)$
国海证券预计公司AI制药业务收入将逐渐提升，预测2026/2027/2028年营业收入分别为10.33/13.98/18.15亿元，归母净利润分别为0.04/0.89/2.35亿元
$晶泰控股(02228)$ 国海证券预计公司AI制药业务收入将逐渐提升，预测2026/2027/2028年营业收入分别为10.33/13.98/18.15...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
木棉花的棉
·
07-08
$晶泰控股(02228)$
此前公司与国际知名药企达成超4亿美元AI药物发现战略合作，回购计划也开始实施了，对晶态的市值是比较有信心的
$晶泰控股(02228)$ 此前公司与国际知名药企达成超4亿美元AI药物发现战略合作，回购计划也开始实施了，对晶态的市值是比较有信心的
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
电白小白15
·
07-08
$晶泰控股(02228)$
三位创始人均为MIT物理博士，技术背景深厚，激励机制匹配其长期主义基因
$晶泰控股(02228)$ 三位创始人均为MIT物理博士，技术背景深厚，激励机制匹配其长期主义基因
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
·
07-06
$晶泰控股(02228)$
公司公告明确“归属条件含综合业绩评估”，非单一财务指标，涵盖技术转化、客户拓展、团队建设
$晶泰控股(02228)$ 公司公告明确“归属条件含综合业绩评估”，非单一财务指标，涵盖技术转化、客户拓展、团队建设
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
木棉花的棉
·
07-06
$晶泰控股(02228)$
这段时间的创新药回升的趋势比较明显，正常跟AI概念的结合，估值应该远不止现在这个情况
$晶泰控股(02228)$ 这段时间的创新药回升的趋势比较明显，正常跟AI概念的结合，估值应该远不止现在这个情况
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
晶泰控股
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
https://www.xtalpi.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。
05-05
须予披露的交易
须予披露交易认购理财产品
须予披露交易认购理财产品
04-17
股份购回
建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划；及股东周年大会通告
建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划；及股东周年大会通告
04-17
年度报告
2025年度报告
2025年度报告
03-25
年度报告
截至2025年12月31日止年度的年度业绩公告
截至2025年12月31日止年度的年度业绩公告
03-03
内幕消息
正面盈利预告扭亏为盈
正面盈利预告扭亏为盈
01-28
股份发行
完成发行2,866,000,000港元于2027年到期的零息可转换债券
完成发行2,866,000,000港元于2027年到期的零息可转换债券
01-08
股份发行
建议发行2,866,000,000港元于2027年到期的零息可转换债券
建议发行2,866,000,000港元于2027年到期的零息可转换债券
2025-09-16
半年度报告
2025中期报告
2025中期报告
2025-09-16
半年度报告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
2025-09-04
股份发行
完成根据一般授权配售新股份
完成根据一般授权配售新股份
2025-08-29
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2025-08-27
半年度报告
截至2025年6月30日止六个月的中期业绩公告
截至2025年6月30日止六个月的中期业绩公告
2025-08-12
内幕消息
正面盈利预告
正面盈利预告
2025-05-11
须予披露的交易
有关收购目标公司90%股权之须予披露交易
有关收购目标公司90%股权之须予披露交易
2025-04-07
股份购回
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
分时
5日
日
周
月
数据加载中...
最高
7.700
今开
7.630
量比
1.84
最低
7.090
昨收
7.720
换手率
1.65%
热议股票
{"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"02228","data":{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":7.41,"timestamp":1784013893126,"preClose":7.72,"halted":0,"volume":71065760,"delay":0,"changeRate":-0.04015544041450772,"floatShares":4303000000,"shares":4303000000,"eps":0.034670313736862315,"marketStatus":"交易中","change":-0.31,"latestTime":"07-14 15:24:53","open":7.63,"high":7.7,"low":7.09,"amount":516837468,"amplitude":0.079016,"askPrice":7.42,"askSize":27000,"bidPrice":7.41,"bidSize":159000,"shortable":3,"etf":0,"ttmEps":0.034670313736862315,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784016600000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":7.72,"openAndCloseTimeList":[[1783992600000,1784001600000],[1784005200000,1784016000000]],"volumeRatio":1.843552,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.585652680389272","cardData":[{"tweetId":"585652680389272","author":{"authorId":"3549961257478316","idStr":"3549961257478316","name":"虾米焗芝士","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":63,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰与代谢疾病领域龙头甘李药业联合共建了“AI智肽递送实验室”，重点围绕代谢性慢病领域开展研究，标志着双方在AI赋能多肽药物研发领域的合作步入全面深化阶段。","plainDigest":"$晶泰控股(02228)$ 晶泰与代谢疾病领域龙头甘李药业联合共建了“AI智肽递送实验室”，重点围绕代谢性慢病领域开展研究，标志着双方在AI赋能多肽药物研发领域的合作步入全面深化阶段。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1784013041107,"gmtModify":1784013043298,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":51,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/585652680389272","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":164,"displayRows":4,"foldSize":0,"authorId":"3549961257478316"}]},{"cardType":"TWEET","cardId":"TWEET.585605272125632","cardData":[{"tweetId":"585605272125632","author":{"authorId":"4193625296607780","idStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":7,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰控股的核心价值在于其“AI+药物发现”和“智能自动化解决方案”业务。","plainDigest":"$晶泰控股(02228)$ 晶泰控股的核心价值在于其“AI+药物发现”和“智能自动化解决方案”业务。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1784000136345,"gmtModify":1784000138272,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":88,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/585605272125632","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":81,"displayRows":4,"foldSize":0,"authorId":"4193625296607780"}]},{"cardType":"TWEET","cardId":"TWEET.585398707262488","cardData":[{"tweetId":"585398707262488","author":{"authorId":"3574483855983034","idStr":"3574483855983034","name":"行稳致远之","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","name":"实盘交易者","description":"完成一笔实盘交易","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":27,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 晶泰合作开发的候选药物SIGX1094 1期临床安全性良好，预计2026年第三季度进入2期临床，已获FDA孤儿药资格及快速通道认定","plainDigest":"$晶泰控股(02228)$ 晶泰合作开发的候选药物SIGX1094 1期临床安全性良好，预计2026年第三季度进入2期临床，已获FDA孤儿药资格及快速通道认定","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783951042071,"gmtModify":1783952535358,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":202,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/585398707262488","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":126,"displayRows":4,"foldSize":0,"authorId":"3574483855983034"}]},{"cardType":"TWEET","cardId":"TWEET.584231850644024","cardData":[{"tweetId":"584231850644024","author":{"authorId":"3549961257478316","idStr":"3549961257478316","name":"虾米焗芝士","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":63,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰之所以值得，核心在于它规避了亲自下场去做药的风险，却又通过诸多捆绑可以分得最终的果实，把创新药的研发做成了进可攻、退可守的确定性生意。","plainDigest":"$晶泰控股(02228)$ 晶泰之所以值得，核心在于它规避了亲自下场去做药的风险，却又通过诸多捆绑可以分得最终的果实，把创新药的研发做成了进可攻、退可守的确定性生意。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783666243696,"gmtModify":1783666245800,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":407,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/584231850644024","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":150,"displayRows":4,"foldSize":0,"authorId":"3549961257478316"}]},{"cardType":"TWEET","cardId":"TWEET.584196367102112","cardData":[{"tweetId":"584196367102112","author":{"authorId":"4184380269673420","idStr":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":14,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 港股创新药ETF（513780）近日明显上涨，晶泰为成分股核心引擎，板块共振效应显著","plainDigest":"$晶泰控股(02228)$ 港股创新药ETF（513780）近日明显上涨，晶泰为成分股核心引擎，板块共振效应显著","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783656164249,"gmtModify":1783656166293,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":116,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/584196367102112","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":88,"displayRows":4,"foldSize":0,"authorId":"4184380269673420"}]},{"cardType":"TWEET","cardId":"TWEET.583981906740336","cardData":[{"tweetId":"583981906740336","author":{"authorId":"4133076063240230","idStr":"4133076063240230","name":"标杆选手","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":26,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 国海证券预计公司AI制药业务收入将逐渐提升，预测2026/2027/2028年营业收入分别为10.33/13.98/18.15亿元，归母净利润分别为0.04/0.89/2.35亿元","plainDigest":"$晶泰控股(02228)$ 国海证券预计公司AI制药业务收入将逐渐提升，预测2026/2027/2028年营业收入分别为10.33/13.98/18.15亿元，归母净利润分别为0.04/0.89/2.35亿元","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783605147406,"gmtModify":1783605149929,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":241,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/583981906740336","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":148,"displayRows":4,"foldSize":0,"authorId":"4133076063240230"}]},{"cardType":"TWEET","cardId":"TWEET.583530395382840","cardData":[{"tweetId":"583530395382840","author":{"authorId":"4119142612662340","idStr":"4119142612662340","name":"木棉花的棉","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":42,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 此前公司与国际知名药企达成超4亿美元AI药物发现战略合作，回购计划也开始实施了，对晶态的市值是比较有信心的","plainDigest":"$晶泰控股(02228)$ 此前公司与国际知名药企达成超4亿美元AI药物发现战略合作，回购计划也开始实施了，对晶态的市值是比较有信心的","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783494913691,"gmtModify":1783494915893,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":174,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/583530395382840","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":118,"displayRows":4,"foldSize":0,"authorId":"4119142612662340"}]},{"cardType":"TWEET","cardId":"TWEET.583481103180144","cardData":[{"tweetId":"583481103180144","author":{"authorId":"4218363023229180","idStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 三位创始人均为MIT物理博士，技术背景深厚，激励机制匹配其长期主义基因","plainDigest":"$晶泰控股(02228)$ 三位创始人均为MIT物理博士，技术背景深厚，激励机制匹配其长期主义基因","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783482870422,"gmtModify":1783482873049,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":306,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/583481103180144","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":82,"displayRows":4,"foldSize":0,"authorId":"4218363023229180"}]},{"cardType":"TWEET","cardId":"TWEET.582861376726160","cardData":[{"tweetId":"582861376726160","author":{"authorId":"4218427800237090","idStr":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":9,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 公司公告明确“归属条件含综合业绩评估”，非单一财务指标，涵盖技术转化、客户拓展、团队建设","plainDigest":"$晶泰控股(02228)$ 公司公告明确“归属条件含综合业绩评估”，非单一财务指标，涵盖技术转化、客户拓展、团队建设","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783331633260,"gmtModify":1783331635399,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":460,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/582861376726160","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":99,"displayRows":4,"foldSize":0,"authorId":"4218427800237090"}]},{"cardType":"TWEET","cardId":"TWEET.582836815910008","cardData":[{"tweetId":"582836815910008","author":{"authorId":"4119142612662340","idStr":"4119142612662340","name":"木棉花的棉","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":42,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 这段时间的创新药回升的趋势比较明显，正常跟AI概念的结合，估值应该远不止现在这个情况","plainDigest":"$晶泰控股(02228)$ 这段时间的创新药回升的趋势比较明显，正常跟AI概念的结合，估值应该远不止现在这个情况","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1783325585226,"gmtModify":1783325587259,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":474,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/582836815910008","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":97,"displayRows":4,"foldSize":0,"authorId":"4119142612662340"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21211134","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGRmij7qsS6","pdf_url":"https://static.tigerbbs.com/56a6aec258e940889211e4625d67d714","pub_time":1777986600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"须予披露交易认购理财产品","symbol":"02228","title":"须予披露交易认购理财产品","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050501807_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2026-05-05 21:10","pubTimestamp":1777986600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21024850","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7XYwiaaS4g","pdf_url":"https://static.tigerbbs.com/97cb00a1170c4ea98d78f91ca4a13164","pub_time":1776430500000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划；及股东周年大会通告","symbol":"02228","title":"建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划；及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0417/2026041701564_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 修订宪章文件 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-04-17 20:55","pubTimestamp":1776430500,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21024582","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEnJZbfW3VJ","pdf_url":"https://static.tigerbbs.com/cb80db131a3e4feabcbd9ea90fd86bf7","pub_time":1776430380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年度报告","symbol":"02228","title":"2025年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0417/2026041701552_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-17 20:53","pubTimestamp":1776430380,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20882806","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7AnYFRAYBq","pdf_url":"https://static.tigerbbs.com/469f490ba0aa429db81a7ca6999de348","pub_time":1774433880000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年12月31日止年度的年度业绩公告","symbol":"02228","title":"截至2025年12月31日止年度的年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501036_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-25 18:18","pubTimestamp":1774433880,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20789101","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEoi6K1CA4P","pdf_url":"https://static.tigerbbs.com/624382e7d5944af4918e2c8bb786cfd9","pub_time":1772532000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告扭亏为盈","symbol":"02228","title":"正面盈利预告扭亏为盈","titleType":"内幕消息","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0303/2026030301646_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Insider information","event_type":"important_notice","event_name":"内幕消息","pubTime":"2026-03-03 18:00","pubTimestamp":1772532000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20669990","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAagr7f4MeA","pdf_url":"https://static.tigerbbs.com/8e2284ffb0a641608e4f658070a8d3aa","pub_time":1769595780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成发行2,866,000,000港元于2027年到期的零息可转换债券","symbol":"02228","title":"完成发行2,866,000,000港元于2027年到期的零息可转换债券","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0128/2026012800648_c.pdf","us_notice_code":"公告及通告 - [发行可转换证券 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-01-28 18:23","pubTimestamp":1769595780,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20613566","market":"hk","labels":[],"media":"港交所","original_id":"N.HKpFZCS5oMAD","pdf_url":"https://static.tigerbbs.com/d6ba8be361e145fa89bb24fe3209cc6a","pub_time":1767826200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","symbol":"02228","title":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0108/2026010800042_c.pdf","us_notice_code":"公告及通告 - [发行可转换证券 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-01-08 06:50","pubTimestamp":1767826200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173334","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2NG2aVqHUH","pdf_url":"https://static.tigerbbs.com/81513848524a4cff837ccefaeddc7c75","pub_time":1758017340000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025中期报告","symbol":"02228","title":"2025中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600967_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 18:09","pubTimestamp":1758017340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173157","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9CcnPXRvWr","pdf_url":"https://static.tigerbbs.com/464bf940313f4110b5256b74bb451a75","pub_time":1758015480000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","symbol":"02228","title":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600877_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 17:38","pubTimestamp":1758015480,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20127960","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5uPwhddh4N","pdf_url":"https://static.tigerbbs.com/0ed7f5f3197248879b2ce690495f6532","pub_time":1756978200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股份","symbol":"02228","title":"完成根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090401265_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-09-04 17:30","pubTimestamp":1756978200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20097849","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHz6WwQom6t","pdf_url":"https://static.tigerbbs.com/1d463f3b4c3048008f5b11e85aa65bd1","pub_time":1756426560000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"02228","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900312_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-08-29 08:16","pubTimestamp":1756426560,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20068769","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8wg8kqwQGB","pdf_url":"https://static.tigerbbs.com/b22ada1d864c42d594b4ff0fffc892cd","pub_time":1756289400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月的中期业绩公告","symbol":"02228","title":"截至2025年6月30日止六个月的中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082701124_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-27 18:10","pubTimestamp":1756289400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19973118","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2EiNd9dsQV","pdf_url":"https://static.tigerbbs.com/ad28295d8114435c95c09364a773b8bb","pub_time":1754949960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"02228","title":"正面盈利预告","titleType":"内幕消息","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081200010_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Insider information","event_type":"important_notice","event_name":"内幕消息","pubTime":"2025-08-12 06:06","pubTimestamp":1754949960,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19626106","market":"hk","labels":[],"media":"港交所","original_id":"N.HK27zCzSG9a4","pdf_url":"https://static.tigerbbs.com/fac64624a5bd419b91583d0552740168","pub_time":1746957900000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关收购目标公司90%股权之须予披露交易","symbol":"02228","title":"有关收购目标公司90%股权之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0511/2025051100004_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2025-05-11 18:05","pubTimestamp":1746957900,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19356689","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGfVm67qcMV","pdf_url":"https://static.tigerbbs.com/664ac2d91e4c4411b9354c87cea0e1a7","pub_time":1744027920000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","symbol":"02228","title":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0407/2025040702158_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-04-07 20:12","pubTimestamp":1744027920,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.0574},{"period":"1month","weight":0.0966},{"period":"3month","weight":-0.2025},{"period":"6month","weight":-0.4474},{"period":"1year","weight":0.391},{"period":"ytd","weight":-0.1839}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.0641},{"period":"6month","weight":-0.1032},{"period":"1year","weight":0.0031},{"period":"ytd","weight":-0.0553}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"aProfile":null}}}